It works by mimicking two incretin hormones simultaneously, reducing appetite, slowing gastric emptying, improving insulin sensitivity, and promoting significant weight loss in clinical trials
The steps include selecting protective groups and amino acid sequences, synthesizing carriers, measuring mass, linking the first amino acid, repeatedly adding amino acids and deprotection steps, determining purity and quality, and separating and purifying
SAHPRA is monitoring the supply chain as well as the online platforms for unregistered, substandard, and falsified medicines containing or claiming to contain semaglutide
Dietary changes often accompany GLP-1 therapy, both as a result of reduced appetite and as part of comprehensive weight management programmes